Rivian’s AI Bet Ignites Investor Optimism as Autonomy Vision Sharpens
Wall Street cheers Rivian’s clean-sheet approach to self-driving, custom chips, and a clear roadmap toward personal Level 4 autonomy Rivian ...
Tag: News
Oracle Shares Plunge Amid Surging AI Costs and Debt Concerns
Despite record AI demand and a soaring $523 billion backlog, Wall Street reacts sharply to Oracle’s aggressive $50 billion spending ...
Chip Giants Face Legal Firestorm Over Alleged Role in Russian Weapons
Intel, AMD, Texas Instruments, and a Berkshire-owned distributor accused of “willful ignorance” as US-made chips surface in Russian missiles and ...
Carvana Extends Historic Winning Streak Ahead of S&P 500 Debut
Shares surge to record highs as investors reward the company’s resilient online model and long-term momentum Carvana Co. (CNVA) is ...
GE Vernova Rockets to Record High as AI and Electrification Fuel Long-Term Power Demand
A surge in earnings forecasts, shareholder rewards, and data-center-driven energy growth positions GE Vernova as a dominant force in the ...
KULR Technology: Powering AI, Robotics, and Bitcoin Into 2026
With over 1,000 BTC on its balance sheet, growing mining capacity, and critical battery and data-center tech, KULR is positioning ...
Bitcoin Surges to $94,000 as Markets Brace for Federal Reserve’s Next Move
Strategists warn the year-end crypto rally may stall if Chair Powell signals a pause in future rate cuts Bitcoin (BTC) ...
Nvidia Shares Climb as Trump Administration Reportedly Moves to Approve H200 Chip Sales to China
Proposed policy shift reignites debate over AI competition, national security, and the role of U.S. tech giants in China’s rapidly ...
Boeing Completes $4.7 Billion Spirit AeroSystems Acquisition in Major Safety and Quality Overhaul
Reuniting with its former supplier marks a decisive shift away from outsourcing and reflects Boeing’s efforts to rebuild trust after ...
Structure Therapeutics Reports Breakthrough Weight-Loss Results for Oral GLP-1 Candidate Aleniglipron
Phase 2b and ACCESS II studies show up to 15.3% weight reduction with promising tolerability, positioning aleniglipron as a potential ...
